Data as of Mar 11
| -4.05 / -2.25%|
The 22 analysts offering 12-month price forecasts for Alexion Pharmaceuticals Inc have a median target of 186.50, with a high estimate of 214.00 and a low estimate of 119.00. The median estimate represents a +6.00% increase from the last price of 175.95.
The current consensus among 25 polled investment analysts is to Buy stock in Alexion Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.